TNGX · Categories · Form 4

TNGX - SEC Form 4 insider transactions

Tango Therapeutics Inc. (TNGX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for TNGX

• 14d
  SEC Form 4 filed by Crystal Adam

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 28d
  SEC Form 4 filed by Crystal Adam

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 34d
  SEC Form 4 filed by Crystal Adam

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 52d
  President, R&D Crystal Adam sold $303,765 worth of shares (20,251 units at $15.00), decreasing direct ownership by 15% to 112,622 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 62d
  President, R&D Crystal Adam sold $694,208 worth of shares (54,345 units at $12.77), decreasing direct ownership by 29% to 132,873 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 84d
  Chief Financial Officer Beckman Daniella sold $126,531 worth of shares (10,317 units at $12.26) and was granted 44,330 shares, increasing direct ownership by 23% to 184,297 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 84d
  Director, Executive Chair Weber Barbara was granted 37,522 shares and sold $374,294 worth of shares (30,519 units at $12.26), increasing direct ownership by 0.43% to 1,629,254 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 84d
  President, R&D Crystal Adam was granted 47,460 shares and sold $226,300 worth of shares (18,452 units at $12.26), increasing direct ownership by 18% to 187,218 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 108d
  President & CEO Peters Malte was granted 350,000 shares, increasing direct ownership by 2,000% to 367,500 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 114d
  Director Lee Sung was granted 10,000 shares (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 177d
  SEC Form 4 filed by Director Peters Malte

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 185d
  Large owner Third Rock Ventures Iv, L.P. sold $4,846,575 worth of shares (477,401 units at $10.15) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 213d
  Large owner Third Rock Ventures Iv, L.P. sold $4,008,500 worth of shares (500,000 units at $8.02) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 225d
  Large owner Third Rock Ventures Iv, L.P. sold $2,559,329 worth of shares (363,541 units at $7.04) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 233d
  Large owner Third Rock Ventures Iv, L.P. sold $5,108,970 worth of shares (729,365 units at $7.00) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 247d
  Large owner Third Rock Ventures Iv, L.P. sold $2,115,358 worth of shares (302,194 units at $7.00) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 252d
  Large owner Third Rock Ventures Iv, L.P. sold $7,712,760 worth of shares (1,100,000 units at $7.01) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 325d
  Director Peters Malte was granted 6,250 shares, increasing direct ownership by 56% to 17,500 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 325d
  Director Calhoun Lesley Ann was granted 6,250 shares, increasing direct ownership by 100% to 12,500 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 325d
  Director Rothenberg Mace was granted 6,250 shares, increasing direct ownership by 20% to 37,500 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 325d
  Director Ketchum John B was granted 6,250 shares, increasing direct ownership by 43% to 20,937 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 325d
  Director Borisy Alexis was granted 6,250 shares, increasing direct ownership by 56% to 17,500 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 447d
  General Counsel Barry Douglas sold $16,369 worth of shares (5,330 units at $3.07), decreasing direct ownership by 7% to 66,014 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 447d
  Chief Financial Officer Beckman Daniella sold $25,282 worth of shares (8,232 units at $3.07), decreasing direct ownership by 5% to 150,284 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 447d
  Officer Crystal Adam sold $43,866 worth of shares (14,283 units at $3.07), decreasing direct ownership by 8% to 158,210 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 447d
  Chief Executive Officer Weber Barbara sold $57,710 worth of shares (18,791 units at $3.07), decreasing direct ownership by 1% to 1,622,251 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 448d
  Chief Financial Officer Beckman Daniella was granted 26,119 shares, increasing direct ownership by 20% to 158,516 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 448d
  Officer Crystal Adam was granted 53,015 shares, increasing direct ownership by 44% to 172,493 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 448d
  Chief Executive Officer Weber Barbara was granted 105,875 shares, increasing direct ownership by 7% to 1,641,042 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 448d
  General Counsel Barry Douglas was granted 27,363 shares, increasing direct ownership by 62% to 71,344 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 538d
  Large owner Ecor1 Capital, Llc sold $8,435,743 worth of shares (2,700,000 units at $3.12) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 538d
  Boxer Capital Management, Llc sold $9,671,200 worth of shares (3,080,000 units at $3.14) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 549d
  Boxer Capital Management, Llc sold $4,348,710 worth of shares (633,000 units at $6.87), decreasing direct ownership by 9% to 6,690,642 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 553d
  Boxer Capital Management, Llc sold $6,101,250 worth of shares (875,000 units at $6.97), decreasing direct ownership by 11% to 7,323,642 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 590d
  Large owner Third Rock Ventures Iv, L.P. sold $709,756 worth of shares (67,400 units at $10.53) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 598d
  Large owner Third Rock Ventures Iv, L.P. sold $867,135 worth of shares (75,000 units at $11.56) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 601d
  SEC Form 4 filed by Davis Aaron I.

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 602d
  Large owner Third Rock Ventures Iv, L.P. sold $2,029,702 worth of shares (175,000 units at $11.60) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 609d
  Large owner Third Rock Ventures Iv, L.P. sold $288,665 worth of shares (25,000 units at $11.55) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 618d
  Large owner Third Rock Ventures Iv, L.P. sold $2,835,368 worth of shares (285,000 units at $9.95) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 637d
  Large owner Third Rock Ventures Iv, L.P. sold $2,316,494 worth of shares (235,000 units at $9.86) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 639d
  Large owner Third Rock Ventures Iv, L.P. sold $491,950 worth of shares (50,000 units at $9.84) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 643d
  Large owner Third Rock Ventures Iv, L.P. sold $2,955,931 worth of shares (300,599 units at $9.83) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 645d
  Large owner Third Rock Ventures Iv, L.P. sold $3,793,446 worth of shares (387,740 units at $9.78) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 647d
  Large owner Third Rock Ventures Iv, L.P. sold $1,878,479 worth of shares (191,490 units at $9.81) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 651d
  Large owner Third Rock Ventures Iv, L.P. sold $5,386,339 worth of shares (550,171 units at $9.79) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 666d
  Mva Investors, Llc sold $2,055,314 worth of shares (234,731 units at $8.76) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 691d
  Mva Investors, Llc sold $985,880 worth of shares (140,000 units at $7.04) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 692d
  Peters Malte was granted 6,250 shares, increasing direct ownership by 125% to 11,250 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 692d
  Rothenberg Mace was granted 6,250 shares, increasing direct ownership by 125% to 11,250 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 692d
  Calhoun Lesley Ann was granted 6,250 shares, increasing direct ownership by 25% to 6,250 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 692d
  Ketchum John B was granted 4,687 shares, increasing direct ownership by 47% to 14,687 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 692d
  Borisy Alexis was granted 6,250 shares, increasing direct ownership by 125% to 11,250 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 726d
  Mva Investors, Llc sold $1,580,850 worth of shares (210,000 units at $7.53) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 799d
  Third Rock Ventures Iv, L.P. sold $1,950,000 worth of shares (162,500 units at $12.00) (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 811d
  Weber Barbara sold $115,052 worth of shares (9,138 units at $12.59), decreasing direct ownership by 0.59% to 1,535,167 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 811d
  Barry Douglas sold $34,951 worth of shares (2,776 units at $12.59), decreasing direct ownership by 6% to 43,981 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 811d
  Beckman Daniella sold $46,900 worth of shares (3,725 units at $12.59), decreasing direct ownership by 3% to 132,397 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 811d
  Crystal Adam sold $105,395 worth of shares (8,371 units at $12.59), decreasing direct ownership by 7% to 119,478 units (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
• 815d
  Beckman Daniella was granted 39,413 shares (SEC Form 4)

  4 - Tango Therapeutics, Inc. (0001819133) (Issuer)

Other TNGX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends